Japan Edges Closer to Parkinson’s Breakthrough With Groundbreaking Brain Cell Therapy
In a major stride toward redefining treatment for Parkinson’s disease, Japanese pharmaceutical firm Sumitomo Pharma has formally requested approval from regulators to commercialize a cutting-edge...